Gene: ZNF528
Official Full Name: zinc finger protein 528provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24886 | ZNF528 Knockout cell line (HeLa) | Human | ZNF528 | 1:3~1:6 | Negative | Online Inquiry |
KO24887 | ZNF528 Knockout cell line (HEK293) | Human | ZNF528 | 1:3~1:6 | Negative | Online Inquiry |
ZNF528 Gene Knockout Cell Lines are genetically engineered cell lines designed to lack the ZNF528 gene, a crucial regulator implicated in various biological processes including cellular proliferation, differentiation, and apoptosis. These knockout cell lines are generated using state-of-the-art CRISPR-Cas9 gene editing technology, which allows for precise modifications in the genome, providing a robust platform for exploring the functional roles of the ZNF528 gene in a controlled environment.
The primary function of ZNF528 Gene Knockout Cell Lines is to serve as a vital tool in understanding gene function and its downstream effects. By examining these cell lines, researchers can elucidate the pathways in which ZNF528 is involved, as well as its impact on cellular responses to stimuli, disease states, and therapeutic interventions. The ability to study ZNF528 knockout cells enables scientists to investigate the gene's role in pathology, particularly in cancers and metabolic disorders.
The scientific importance of these cell lines extends to both basic research and clinical applications. In research settings, they can aid in the identification of novel gene interactions and regulatory networks, thereby driving advancements in gene therapy and precision medicine. Clinically, a better understanding of ZNF528’s role could lead to the development of targeted therapies or biomarkers for disease progression.
Compared to alternative models, such as transient knockdown techniques, ZNF528 Gene Knockout Cell Lines provide a stable and reproducible system that allows for long-term studies and more consistent data. Furthermore, these cell lines can facilitate high-throughput screening of pharmaceutical compounds aimed at restoring normal cellular function, offering researchers a unique advantage in drug discovery.
For researchers and clinicians keen on unraveling the complexities of gene function and its implications in health and disease, ZNF528 Gene Knockout Cell Lines represent an invaluable resource. Ultimately, our company prides itself on delivering high-quality biological products grounded in cutting-edge genetic engineering techniques, ensuring that our customers have access to the best tools for their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.